Lacticaseibacillus casei

From WikiMD's WELLNESSPEDIA

(Redirected from Lactobacillus casei)

Lacticaseibacillus casei is a species of Gram-positive, rod-shaped bacteria that is used extensively in the fermentation of dairy products. It is a member of the Lacticaseibacillus genus, which is part of the larger Lactobacillaceae family.

Taxonomy[edit]

The species was first described in 1933 by Minoru Shirota, who isolated it from a sample of fermented milk. It was originally classified as Lactobacillus casei, but was reclassified as Lacticaseibacillus casei in 2020 following a major revision of the Lactobacillus genus.

Characteristics[edit]

Lacticaseibacillus casei is a facultative anaerobe, meaning it can grow in both the presence and absence of oxygen. It is catalase-negative and does not produce spores. The bacteria are rod-shaped and typically arranged in short chains.

Uses[edit]

Lacticaseibacillus casei is used in the production of a variety of fermented dairy products, including yogurt, cheese, and kefir. It is also used in the production of probiotic supplements, due to its potential health benefits.

Health Benefits[edit]

Research has suggested that Lacticaseibacillus casei may have a number of health benefits. These include improving digestive health, boosting the immune system, and potentially helping to prevent certain types of cancer. However, more research is needed to fully understand these potential benefits.

See Also[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.